Literature DB >> 6252908

Experimental basis for the clinical use of diphosphonates in Paget's disease of bone.

H Fleisch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252908     DOI： 10.1002/art.1780231014

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

1.  Corticosteroid induced osteoporosis in severe menstrual asthma. Steroid sparing drugs may be useful.

Authors:  A U Wells
Journal:  BMJ       Date:  1992-08-15

2.  [Diphosphonate for the prevention of an increased ossification process].

Authors:  W Forth
Journal:  Klin Wochenschr       Date:  1986-06-16

Review 3.  Paget's disease of bone.

Authors:  D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-12

4.  Paget's disease of bone.

Authors:  G J Strewler
Journal:  West J Med       Date:  1984-05

5.  The bisphosphonates HEBP and AHPrBP but not AHBP inhibit mineral mobilization and lysosomal enzyme release from mouse calvarial bones in tissue culture.

Authors:  U Lerner; A Larsson
Journal:  Experientia       Date:  1984-09-15

6.  Effect of dichloromethylene diphosphonate (Cl2MDP) on immune function in breast cancer patients with bone metastases.

Authors:  R Markkula; H Repo; M Leirisalo; C Blomqvist; I Elomaa
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse.

Authors:  C R Hoggarth; R Bennett; P T Daley-Yates
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.